Stock Alert: Kaleido Biosciences Jumps 56%

Shares of Kaleido Biosciences Inc. (KLDO) are surging almost 56 percent or $2.83 in Thursday's morning trade at $7.92 despite no specific news that could influence the stock.

U.S. stocks are little changed in volatile trading on Thursday after opening lower amid lingering concerns about the global economic outlook as Europe grapples with a second wave of coronavirus infections. In a sign of continued weakness in the labor market, the Labor Department released a report showing an unexpected uptick in first-time claims for U.S. unemployment benefits in the week ended September 19.

Lexington, Massachusetts-based Kaleido Biosciences is a clinical-stage healthcare company that develops microbiome metabolic therapies.

The stock has traded in a range of $2.82 to $10.00 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Editors Pick
Google has revoked its three-year ban on cryptocurrency-related ads on its sites under the search giants' new ad services policy. This action will now allow cryptocurrency exchanges and wallets certified by Google to advertise their products and services on Google's network, beginning August 3, 2021. The UK's competition regulator said Friday that it has secured commitments from Google to address concerns about the tech giant's proposal to remove third-party cookies from Chrome browser. Archer Aviation, a developer of electric vertical take-off and landing or eVTOL aircraft, unveiled its autonomous electric two-seater aircraft, named "Maker", marking a milestone towards its commercial launch. The California-based air mobility company, which has already received orders from United Airlines, will use its inaugural aircraft prototype for testing as it works towards certification.
Follow RTT